Drugs / CKD-843 A
last change Oct 2023 re-read 3 minutes ago

CKD-843 A

Developed for
alopecia
Investigated by
Chong Kun Dang Pharmaceutical

Trials 2

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05587699 Nov 2022 → Sep 2023 alopecia Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT04805606 Apr → Dec 2021 alopecia Chong Kun Dang Pharmaceutical Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as CKD-843 A ClinicalTrials.gov intervention name — accepted as the source's own label NCT05587699 ↗
1

NCT04805606 ↗